JP2023510982A5 - - Google Patents
Info
- Publication number
- JP2023510982A5 JP2023510982A5 JP2022544146A JP2022544146A JP2023510982A5 JP 2023510982 A5 JP2023510982 A5 JP 2023510982A5 JP 2022544146 A JP2022544146 A JP 2022544146A JP 2022544146 A JP2022544146 A JP 2022544146A JP 2023510982 A5 JP2023510982 A5 JP 2023510982A5
- Authority
- JP
- Japan
- Prior art keywords
- monoclonal antibody
- seq
- variable region
- chain variable
- lag3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010069008 | 2020-01-21 | ||
| CN202010069008.9 | 2020-01-21 | ||
| PCT/CN2021/072610 WO2021147837A1 (zh) | 2020-01-21 | 2021-01-19 | 抗lag3单克隆抗体及其制备方法和应用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023510982A JP2023510982A (ja) | 2023-03-15 |
| JP2023510982A5 true JP2023510982A5 (cg-RX-API-DMAC10.html) | 2024-01-26 |
| JP7692918B2 JP7692918B2 (ja) | 2025-06-16 |
| JP7692918B6 JP7692918B6 (ja) | 2025-07-17 |
Family
ID=76993109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022544146A Active JP7692918B6 (ja) | 2020-01-21 | 2021-01-19 | 抗ｌａｇ３モノクローナル抗体、その製造方法および使用 |
Country Status (10)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
| EP4410835A4 (en) * | 2021-09-29 | 2025-09-24 | Akeso Biopharma Inc | ANTI-LAG3 ANTIBODY, PHARMACEUTICAL COMPOSITION AND USE |
| WO2023138677A1 (en) * | 2022-01-24 | 2023-07-27 | Crown Bioscience Inc. (Taicang) | Novel anti-lag3 antibodies and derivative products |
| CN119950708B (zh) * | 2023-06-05 | 2025-12-26 | 北京东方百泰生物科技股份有限公司 | 一种抗il-11单克隆抗体的药物制剂 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| RS64268B1 (sr) | 2013-09-20 | 2023-07-31 | Bristol Myers Squibb Co | Kombinacija anti-lag-3 antitela i anti-pd-1 antitela za lečenje tumora |
| JO3663B1 (ar) * | 2014-08-19 | 2020-08-27 | Merck Sharp & Dohme | الأجسام المضادة لمضاد lag3 وأجزاء ربط الأنتيجين |
| CN114853891A (zh) * | 2015-07-22 | 2022-08-05 | 索伦托药业有限公司 | 与lag3结合的抗体治疗剂 |
| TWI756187B (zh) * | 2015-10-09 | 2022-03-01 | 美商再生元醫藥公司 | 抗ｌａｇ３抗體及其用途 |
| US20190330336A1 (en) * | 2015-11-19 | 2019-10-31 | Sutro Biopharma, Inc. | Anti-lag3 antibodies, compositions comprising anti-lag3 antibodies and methods of making and using anti-lag3 antibodies |
| SI4339615T1 (sl) | 2016-09-16 | 2026-01-30 | Shanghai Henlius Biotech, Inc. | Protitelesa anti-pd-1 za uporabo pri zdravljenju raka |
| UA128387C2 (uk) * | 2017-04-05 | 2024-07-03 | Ф. Хоффманн-Ля Рош Аг | Антитіло до lag3 |
| US11339218B2 (en) * | 2017-05-10 | 2022-05-24 | Zhejiang Shimai Pharmaceutical Co., Ltd. | Human monoclonal antibodies against LAG3 and uses thereof |
| WO2019164219A1 (en) * | 2018-02-20 | 2019-08-29 | Institute For Basic Science | Anti-angiopoietin-2 antibodies and uses thereof |
| CN110204614B (zh) | 2018-02-28 | 2022-07-12 | 广州誉衡生物科技有限公司 | 抗人lag-3单克隆抗体及其制备方法和用途 |
| CN110305215B (zh) | 2018-03-20 | 2023-11-03 | 基石药业 | 新型抗lag-3抗体多肽 |
| CN110343179B (zh) | 2018-04-02 | 2024-03-08 | 上海博威生物医药有限公司 | 结合淋巴细胞活化基因-3(lag-3)的抗体及其用途 |
| CN110172099B (zh) | 2018-08-16 | 2020-03-03 | 上海健信生物医药科技有限公司 | 抗lag-3人源化单克隆抗体分子，抗原结合片段及其医药用途 |
-
2021
- 2021-01-19 JP JP2022544146A patent/JP7692918B6/ja active Active
- 2021-01-19 US US17/759,180 patent/US20230074657A1/en active Pending
- 2021-01-19 CN CN202180008891.3A patent/CN114945595A/zh active Pending
- 2021-01-19 CA CA3165211A patent/CA3165211A1/en active Pending
- 2021-01-19 KR KR1020227028342A patent/KR20220131279A/ko active Pending
- 2021-01-19 BR BR112022013544A patent/BR112022013544A2/pt unknown
- 2021-01-19 AU AU2021210029A patent/AU2021210029A1/en active Pending
- 2021-01-19 EP EP21744582.4A patent/EP4095159A4/en active Pending
- 2021-01-19 WO PCT/CN2021/072610 patent/WO2021147837A1/zh not_active Ceased
-
2022
- 2022-07-26 ZA ZA2022/08339A patent/ZA202208339B/en unknown